Digital Health is now a major focus not only for the life sciences and healthcare industry, but also for technology, telecoms, and retail companies, who are expanding their services and products into this space. From medical apps, digital therapeutics and AI diagnostic tools to blood glucose monitors, medical software and electronic personal health records, digital technologies play an integral role in how we prevent, treat, and manage health conditions.
Join us for our Digital Health event on Thursday 20th October in Brussels, where our international Life Sciences and Tech experts will come together and discuss some of the key legal issues and trends surrounding this dynamic topic, including data, regulation, privacy, tech contracting, financing and intellectual property.
We will also be joined by special guest speakers from Amazon, IQVIA, Takeda, Novartis,Novo Nordisk and Edoardo Monopoli, CEO, OXYGY and Vera Pellegrin, Senior Manager, OXYGY , who will give their industry perspectives on how digital technologies are transforming the life sciences and healthcare world.
The event will be a full-day interactive mix of plenary, panel and break-out sessions, finishing off with networking drinks and canapes.
We look forward to welcoming you in Brussels!
09:00 - 09:30
Breakfast and Registration
09:30 - 11:00
How digitalisation is impacting the Life Sciences & Healthcare industry
Key areas of business which are susceptible to digitalisation (e.g., patient interaction, patient monitoring, back office, supply chain and logistics etc.
Creation of new key areas of business (e.g., direct patient interaction for life sciences companies)
New emerging technologies that will enable or drive these changes. The roles of blockchain, tokens, AI, data, and digital IDs
Regulatory landscape: How is law and regulation applicable to LS&H coping with current tech-driven change? What are the key trends?
Focus on move towards data centricity: What does this look like for LSH organisations, what are the general / organisation-level challenges, what are the issues being faced by legal teams in enabling this?
Followed by a panel discussion
11:00 - 11:30
11:30 - 12:30
Breakout session one: Getting a digital healthcare product to market
Thought process / decision tree of getting a digital healthcare product to market
Deciphering which products or services fall into specific regulatory regimes
Handling and contracting for the relevant technologies / key tech related issues and challenges:
Key supplier / customer relationships and tech-driven legal issues to consider when designed contracting frameworks
Ts & Cs that are both legally compliant but also achieve efficient commercial outcomes
Breakout session two: Enabling data driven innovation
Protection, innovation and collaboration as part of data stewardship and the role of lawyers in developing a data innovation strategy
Anonymisation as the boundary between personal and non-personal data
Protection of non-personal data
Trends in data regulation (data localisation and the draft EU Data Act)
Managing data in collaborations and data sharing frameworks
Developing an open data strategy
12:30 - 14:00
14:00 - 14:45
Panel: Digital Collaborations: Tech meets Healthcare
The cultural differences when contracting in healthcare and tech
How to achieve successful collaborations between healthcare providers/life sciences companies and technology companies
Exploring the cultural differences when contracting in healthcare and tech, e.g., to issues such as liability and IP
Which regulatory issues can apply to collaborations and which partner is responsible for ensuring compliance
14:45 - 15:15
15:15 - 16:00
Breakout session three: Protecting and scaling digital healthcare products
IP protection strategies for digital healthcare.
Scale up challenges (financing and investment, cross border expansion etc)
Breakout session four: Planning for success in digitalisation projects
What to think about at the outset of a project
Key tech contracting issues in the lifecycle of a project (including how to successfully deal with implementation and exit)
The differences with contracting for AI vs traditional technologies
Conclusion followed by networking drinks
Boulevard de Waterloo 38, 1000